PRA Health Sciences, Inc. provided earnings guidance for the full year of 2020. For the period, the company expects to achieve total revenues between $3.120 billion and $3.150 billion, GAAP net income per diluted share between $3.23 and $3.35 and adjusted net income per diluted share between $4.61 and $4.71.